REZDIFFRA
Total Payments
$4.1M
Transactions
5,918
Doctors
2,540
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $4.1M | 5,918 | 2,540 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3.0M | 1,071 | 74.1% |
| Food and Beverage | $403,461 | 3,452 | 9.9% |
| Travel and Lodging | $365,575 | 1,135 | 9.0% |
| Honoraria | $194,633 | 44 | 4.8% |
| Consulting Fee | $41,214 | 66 | 1.0% |
| Space rental or facility fees (teaching hospital only) | $40,750 | 7 | 1.0% |
| Education | $5,999 | 141 | 0.1% |
| Grant | $5,000 | 2 | 0.1% |
Top Doctors Receiving Payments for REZDIFFRA — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Internal Medicine | Flushing, NY | $29,574 | 23 |
| , M.D | Hepatology | Baton Rouge, LA | $29,564 | 30 |
| , M.D | Internal Medicine | Cleveland, OH | $29,173 | 20 |
| , M.D., PH. D | Gastroenterology | Burr Ridge, IL | $27,869 | 16 |
| Rashmee Patil | Internal Medicine | Mcallen, TX | $27,781 | 20 |
| , MD | Gastroenterology | Providence, RI | $26,632 | 21 |
| Michael Charlton | Transplant Hepatology | Chicago, IL | $26,106 | 2 |
| , D.O | Gastroenterology | New York, NY | $25,664 | 24 |
| , MD | Gastroenterology | Cleveland, OH | $25,594 | 19 |
| , M.D | Gastroenterology | New York, NY | $25,379 | 24 |
| , MD | Hepatology | New York, NY | $23,641 | 13 |
| , M.D | Hepatology | Pasadena, CA | $23,560 | 18 |
| , MD | Gastroenterology | Hartford, CT | $23,390 | 14 |
| , MD | Transplant Surgery | Los Angeles, CA | $22,954 | 17 |
| , MD., MPH | Gastroenterology | Weston, FL | $22,790 | 22 |
| , M.D | Gastroenterology | Catonsville, MD | $21,656 | 19 |
| , M.D | Internal Medicine | Louisville, KY | $21,363 | 12 |
| , M.D | Hepatology | San Francisco, CA | $21,170 | 18 |
| , M.D., M.P.H | Gastroenterology | Downers Grove, IL | $20,947 | 15 |
| , M.D | Gastroenterology | Parker, CO | $20,776 | 22 |
| , DO | Gastroenterology | Fleming Island, FL | $20,757 | 18 |
| , MD | Gastroenterology | Seattle, WA | $20,434 | 11 |
| , M.D | Gastroenterology | New Orleans, LA | $20,138 | 12 |
| , MD | Hepatology | Chicago, IL | $19,846 | 15 |
| , MD | Gastroenterology | Manhasset, NY | $19,394 | 17 |
Ad
Manufacturing Companies
- Madrigal Pharmaceuticals $4.1M
Product Information
- Type Drug
- Total Payments $4.1M
- Total Doctors 2,540
- Transactions 5,918
About REZDIFFRA
REZDIFFRA is a drug associated with $4.1M in payments to 2,540 healthcare providers, recorded across 5,918 transactions in the CMS Open Payments database. The primary manufacturer is Madrigal Pharmaceuticals.
Payment data is available from 2024 to 2024. In 2024, $4.1M was paid across 5,918 transactions to 2,540 doctors.
The most common payment nature for REZDIFFRA is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3.0M, 74.1% of total).